Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates

Ionis Pharmaceuticals (IONS) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to a loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +218.52%. A quarter ago, it was expected that this drug discovery and development company would post a loss of $1.11 per share when it actually produced a loss of $0.75, delivering a surprise of +32.43%. Over ...